The Joint Center for Radiation Therapy

2015 ◽  
pp. 76-80
Author(s):  
S. Hellman
Keyword(s):  
Radiation Therapy ◽  
Joint Center

Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival.

1985 ◽  
Vol 3 (4) ◽  
pp. 490-494 ◽  
Author(s):  
J S Loeffler ◽  
T J Ervin ◽  
P Mauch ◽  
A Skarin ◽  
H J Weinstein ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Systemic Disease ◽  
Cns Lymphoma ◽  
Primary Lymphoma ◽  
Patterns Of Failure ◽  
Craniospinal Radiation ◽  
The Central Nervous System ◽  
Joint Center ◽  
Hodgkin's Lymphomas ◽  
Cns Lymphomas

Primary lymphomas of the CNS are rare tumors accounting for less than 2% of all extranodal non-Hodgkin's lymphomas. The treatment for this disease has been disappointing. Radiation therapy and surgery have produced consistently poor control of this disease, with a median survival of 15 months. We have reviewed ten cases of primary lymphoma of the CNS treated at the Joint Center for Radiation Therapy or Dana-Farber Cancer Institute (Boston) from 1968 to 1981. All patients had biopsy-proven CNS lymphomas without systemic disease at presentation. In our series, control of CNS lymphoma was seen only in patients receiving craniospinal radiation or CNS-penetrating chemotherapy.

Primary radiation therapy for early breast cancer: The experience at the joint center for radiation therapy

1981 ◽  
Vol 7 (11) ◽  
pp. 1549-1552 ◽  
Author(s):  
Jay R. Harris ◽  
Leslie Botnick ◽  
William D. Bloomer ◽  
John T. Chaffey ◽  
Samuel Hellman
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Early Breast Cancer ◽  
Primary Radiation ◽  
Joint Center

Academic Career Selection and Retention in Radiation Oncology: The Joint Center for Radiation Therapy Experience

2007 ◽  
Vol 68 (1) ◽  
pp. 183-186 ◽  
Author(s):  
Tracy A. Balboni ◽  
Ming-Hui Chen ◽  
Jay R. Harris ◽  
Abram Recht ◽  
Mary Ann Stevenson ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Radiation Oncology ◽  
Academic Career ◽  
Career Selection ◽  
Joint Center

Radiation therapy of seminoma: 17-year experience at the Joint Center for Radiation Therapy

1989 ◽  
Vol 14 (3) ◽  
pp. 203-208 ◽  
Author(s):  
Gilbert S. Lederman ◽  
Terence S. Herman ◽  
Maxine Jochelson ◽  
Barbara J. Silver ◽  
John T. Chaffey ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Joint Center

Medulloblastoma at the joint center for radiation therapy between 1968 and 1984.The influence of radiation dose on the patterns of failure and survival

Cancer ◽  
1988 ◽  
Vol 61 (10) ◽  
pp. 1992-1998 ◽  
Author(s):  
Edward N. Hughes ◽  
John Shillito ◽  
Stephen E. Sallan ◽  
Jay S. Loeffler ◽  
J. Robert Cassady ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Radiation Dose ◽  
Patterns Of Failure ◽  
Joint Center

Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience.

1984 ◽  
Vol 2 (7) ◽  
pp. 719-732 ◽  
Author(s):  
E M Rosen ◽  
J R Cassady ◽  
C N Frantz ◽  
C Kretschmar ◽  
R Levey ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Disease Free Survival ◽  
Stage Iv ◽  
Children's Hospital ◽  
Dana Farber Cancer Institute ◽  
Children’S Hospital ◽  
Stage Iv Disease ◽  
Impact On Survival ◽  
One Year ◽  
Joint Center

The treatment results for 118 patients with neuroblastoma seen at the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital from 1970 to 1980 were analyzed. Patients were treated with a combination of surgery, radiation therapy, and chemotherapy depending on stage and age. Disease-free survival was excellent in all patient groups except those over one year of age with stage IV disease, a group for which currently available therapy cures only a small proportion of patients. Patients with stage III disease and older patients with stage II disease did extremely well (survival of 81% and 89%, respectively) and may have benefited from intensive treatment with all three modalities. Survival for infants (under one year) with stage IV neuroblastoma (90%) has clearly improved with intensive combination chemotherapy. With combination approaches and newer, more effective systemic regimens, a real impact on survival appears to have been made in the last decade. Better approaches will be necessary to cure more than an occasional older patient with stage IV disease.

Sign in / Sign up

Export Citation Format

Share Document